Skip to content
10-Q

Quarterly Report

MOSAIC IMMUNOENGINEERING, INC. CPMV

0001683168-24-003375

← back to feed
Filed
May 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 10, 2024 7.24M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $65.04K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $156.18K
Current Liabilities Q1 2024 · Mar 31, 2024 $4.9M
Current Liabilities Q1 2024 · Dec 31, 2023 $4.73M
Total Liabilities Q1 2024 · Mar 31, 2024 $6.23M
Total Liabilities Q1 2024 · Dec 31, 2023 $6.05M
Current Assets Q1 2024 · Mar 31, 2024 $78.95K
Current Assets Q1 2024 · Dec 31, 2023 $179.53K
Total Assets Q1 2024 · Mar 31, 2024 $78.95K
Total Assets Q1 2024 · Dec 31, 2023 $179.53K
Shares Diluted Q1 2024 · Mar 31, 2023 7.24M sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$171.87K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$5.28M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$4.88M
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.06
Eps Basic Q1 2024 · Mar 31, 2023 −$0.06
Rd Expense Q1 2024 · Mar 31, 2023 $177.9K
Net Income Q1 2024 · Mar 31, 2023 −$399.04K
Operating Income Q1 2024 · Mar 31, 2023 −$459.77K